MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circulationaha.106.628537

Медицинская библиотека · Circulation · 2006

Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study.

Sacher Frédéric, Probst Vincent, Iesaka Yoshito, Jacon Peggy, Laborderie Julien, Mizon-Gérard Frédérique, Mabo Philippe, Reuter Sylvain, Lamaison Dominique, Takahashi Yoshihide, O'Neill Mark D, Garrigue Stéphane, Pierre Bertrand, Jaïs Pierre, Pasquié Jean-Luc, Hocini Mélèze, Salvador-Mazenq Michèle, Nogami Akihiko, Amiel Alain, Defaye Pascal, Bordachar Pierre, Boveda Serge, Maury Philippe, Klug Didier, Babuty Dominique, Haïssaguerre Michel, Mansourati Jacques, Clémenty Jacques, Le Marec Hervé

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Brugada syndrome is an arrhythmogenic disease characterized by an increased risk of sudden cardiac death (SCD) by ventricular fibrillation. At present, an implantable cardioverter-defibrillator (ICD) is the recommended therapy in high-risk patients. This multicenter study reports the outcome of a large series of patients implanted with an ICD for Brugada syndrome.

METHODS AND

RESULTS

All patients (n=220, 46+/-12 years, 183 male) with a type 1 Brugada ECG pattern implanted with an ICD in 14 centers between 1993 and 2005 were investigated. ICD indication was based on resuscitated SCD (18 patients, 8%), syncope (88 patients, 40%), or positive electrophysiological study in asymptomatic patients (99 patients, 45%). The remaining 15 patients received an ICD because of a family history of SCD or nonsustained ventricular arrhythmia. During a mean follow-up of 38+/-27 months, no patient died and 18 patients (8%) had appropriate device therapy (10+/-15 shocks/patient, 26+/-33 months after implantation). The complication rate was 28%, including inappropriate shocks, which occurred in 45 patients (20%, 4+/-3 shocks/patient, 21+/-20 months after implantation). The reasons for inappropriate therapy were lead failure (19 patients), T-wave oversensing (10 patients), sinus tachycardia (10 patients), and supraventricular tachycardia (9 patients). Among implantation parameters, high defibrillation threshold, high pacing threshold, and low R-wave amplitude occurred, respectively, in 12%, 27%, and 15% of cases.

CONCLUSIONS

In this large Brugada syndrome population, a low incidence of arrhythmic events was found, with an annual event rate of 2.6% during a follow-up of >3 years, in addition to a significant risk of device-related complications (8.9%/year). Inappropriate shocks were 2.5 times more frequent than appropriate ones.

Для цитирования: Sacher Frédéric, Probst Vincent, Iesaka Yoshito, Jacon Peggy, Laborderie Julien, Mizon-Gérard Frédérique, Mabo Philippe, Reuter Sylvain, Lamaison Dominique, Takahashi Yoshihide, O'Neill Mark D, Garrigue Stéphane, Pierre Bertrand, Jaïs Pierre, Pasquié Jean-Luc, Hocini Mélèze, Salvador-Mazenq Michèle, Nogami Akihiko, Amiel Alain, Defaye Pascal, Bordachar Pierre, Boveda Serge, Maury Philippe, Klug Didier, Babuty Dominique, Haïssaguerre Michel, Mansourati Jacques, Clémenty Jacques, Le Marec Hervé. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study.. Circulation. 2006. DOI: 10.1161/circulationaha.106.628537.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.